Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.4%

4 terminated/withdrawn out of 118 trials

Success Rate

88.6%

+2.1% vs industry average

Late-Stage Pipeline

8%

10 trials in Phase 3/4

Results Transparency

13%

4 of 31 completed trials have results

Key Signals

7 recruiting4 with results

Enrollment Performance

Analytics

N/A
55(70.5%)
Phase 2
11(14.1%)
Phase 4
7(9.0%)
Phase 3
3(3.8%)
Phase 1
2(2.6%)
78Total
N/A(55)
Phase 2(11)
Phase 4(7)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (118)

Showing 20 of 118 trials
NCT05489380Not ApplicableCompleted

Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance

Role: collaborator

NCT07356258Not Yet Recruiting

Oral Iron in Pregnant Women: How Often to Take It and Its Side Effects and Tolerability

Role: lead

NCT07323901Not ApplicableEnrolling By Invitation

GRAPE-GDM Prospective Comperative Trial - Grape Juice as a Replacement Drink for Gestational Diabetes Screening

Role: lead

NCT02399124Not ApplicableActive Not Recruiting

Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma

Role: collaborator

NCT07288021Phase 4Recruiting

Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)

Role: lead

NCT06966557Recruiting

Nerve Block Treatment for Chronic Jaw Pain

Role: lead

NCT01733771Not ApplicableCompleted

The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients

Role: lead

NCT06865716Not ApplicableActive Not Recruiting

Effects of Early Vagus Nerve Stimulation on Infarct Damage and Functioning After Acute STEMI

Role: lead

NCT04939363Phase 2Completed

A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;

Role: lead

NCT06598813Completed

Pediatric Headche Assessment Using HIT 6

Role: lead

NCT06581185Enrolling By Invitation

Pseudotumor Cerebri Headache Ten Years Outcome

Role: lead

NCT03290976Not ApplicableCompleted

Integrative Medicine for Chemotherapy-Induced Peripheral Neuropathy

Role: collaborator

NCT06515249Not ApplicableRecruiting

Integrative Therapies in Multiple Myeloma

Role: lead

NCT06510530Phase 3Not Yet Recruiting

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

Role: lead

NCT06487169Not Yet Recruiting

Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction

Role: lead

NCT06416267Not Yet Recruiting

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)

Role: collaborator

NCT05599698Not ApplicableRecruiting

Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

Role: lead

NCT05718986Not Yet Recruiting

Familial B-cell Lymphoproliferative Disorders

Role: collaborator

NCT05982249Not ApplicableRecruiting

Hypnosis and Virtual Reality in Bone Marrow Examination

Role: lead

NCT05982262Not ApplicableRecruiting

Naturopathic-pharmacological Consultation in Hematology

Role: lead